Art

J-GLOBAL ID：201802259855076425   Reference number：18A1372237

Comparison of the early effects of vonoprazan, lansoprazole and famotidine on intragastric pH: a three-way crossover study

胃内pHに対するボノプラザン,ランソプラゾールおよびファモチジンの早期効果の比較:3方向交差試験

Author (10)： Ohkuma Kanji (Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine) ,  Iida Hiroshi (Department of Medical Education, Yokohama City University School of Medicine) ,  Inoh Yumi (Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine) ,  Kanoshima Kenji (Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine) ,  Ohkubo Hidenori (Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine) ,  Nonaka Takashi (Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine) ,  Fujita Koji (Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine) ,  Kusakabe Akihiko (Department of General Medicine, Yokohama City University School of Medicine) ,  Inamori Masahiko (Department of Medical Education, Yokohama City University School of Medicine) ,  Nakajima Atsushi (Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine)
Material： Journal of Clinical Biochemistry and Nutrition  (JCBN)
Volume： 63  Issue： 1  Page： 80-83(J-STAGE)  Publication year： 2018 
JST Material Number： X0851A  ISSN： 0912-0009  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *gastric juice secretion ,...
Semi thesaurus term： pH monitoring ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1372237&from=J-GLOBAL&jstjournalNo=X0851A") }}

Author keywords (4)： intragastric acidity ,  vonoprazan ,  lansoprazole ,  famotidine

JST classification (1)： Clinical application of drugs acting on digestive system  (GW09020B)

Substance index (3)： Vonoprazan fumarate ,  Lansoprazole ,  Famotidine

Reference (39)：

• 1 Bytzer P. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol 2003; 98 (Suppl 3): S31-S39.
• 2 Graham DY. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter 2002; 7: 1-8.
• 3 Frazzoni M, De Micheli E, Grisendi A, Savarino V. Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole. Aliment Pharmacol Ther 2003; 17: 235-241.
• 4 Robinson M. Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases. Int J Clin Pract 2005; 59: 709-715.
• 5 Malfertheiner P, Mössner J, Fischbach W, et al. Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Aliment Pharmacol Ther 2003; 18: 615-625.

Terms in the title (8)： 胃 ,  pH ,  ボノプラザン ,  ランソプラゾール ,  ファモチジン ,  早期 ,  3方向 ,  交差試験